Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mervi Taskinen

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Leukemia|September 20, 2019
Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology studyMaria Thastrup, Hanne Vibeke Marquart, Mette Levinsen, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|April 29, 2020
Seizures during treatment of childhood acute lymphoblastic leukemia: A population-based cohort studyStavroula Anastasopoulou, Mats Heyman, Mats A Eriksson, et al.
Pediatric Blood & Cancer|July 23, 2016
Leukemic blasts are present at low levels in spinal fluid in one-third of childhood acute lymphoblastic leukemia casesMette Levinsen, Hanne V Marquart, Line Groth-Pedersen, et al.
European Journal of Haematology|March 7, 2013
Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocolNina Toft, Henrik Birgens, Jonas Abrahamsson, et al.
Blood|October 5, 2017
Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2Hasan Hashem, Ashish R Kumar, Ingo Müller, et al.
Haematologica|March 31, 2022
Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypesStavroula Anastasopoulou, Rikke Linnemann Nielsen, Bodil Als-Nielsen, et al.
Bone Marrow Transplantation|December 8, 2020
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective studyJan Styczyński, Gloria Tridello, Alienor Xhaard, et al.
Blood|January 29, 2021
RhoG deficiency abrogates cytotoxicity of human lymphocytes and causes hemophagocytic lymphohistiocytosisArtem Kalinichenko, Giovanna Perinetti Casoni, Loïc Dupré, et al.
Haematologica|November 28, 2024
Donor cytomegalovirus serology impacts overall survival in children receiving first unrelated hematopoietic stem cell transplant for acute leukemia: European Society of Bone Marrow Transplantation Pediatric Diseases Working Party StudyElif Ince, Jaques-Emmanuel Galimard, Marianne Ifversen, et al.
Haematologica|November 3, 2025
<i>Erratum</i> to<i>: "</i>Donor cytomegalovirus serology impacts overall survival in children receiving first unrelated hematopoietic stem cell transplant for acute leukemia: European Society of Bone Marrow Transplantation Pediatric Diseases Working Party Study"Elif Ince, Jaques-Emmanuel Galimard, Marianne Ifversen, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Leukemia|September 20, 2019
Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology studyMaria Thastrup, Hanne Vibeke Marquart, Mette Levinsen, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|April 29, 2020
Seizures during treatment of childhood acute lymphoblastic leukemia: A population-based cohort studyStavroula Anastasopoulou, Mats Heyman, Mats A Eriksson, et al.
Pediatric Blood & Cancer|July 23, 2016
Leukemic blasts are present at low levels in spinal fluid in one-third of childhood acute lymphoblastic leukemia casesMette Levinsen, Hanne V Marquart, Line Groth-Pedersen, et al.
European Journal of Haematology|March 7, 2013
Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocolNina Toft, Henrik Birgens, Jonas Abrahamsson, et al.
Blood|October 5, 2017
Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2Hasan Hashem, Ashish R Kumar, Ingo Müller, et al.
Haematologica|March 31, 2022
Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypesStavroula Anastasopoulou, Rikke Linnemann Nielsen, Bodil Als-Nielsen, et al.
Bone Marrow Transplantation|December 8, 2020
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective studyJan Styczyński, Gloria Tridello, Alienor Xhaard, et al.
Blood|January 29, 2021
RhoG deficiency abrogates cytotoxicity of human lymphocytes and causes hemophagocytic lymphohistiocytosisArtem Kalinichenko, Giovanna Perinetti Casoni, Loïc Dupré, et al.
Haematologica|November 28, 2024
Donor cytomegalovirus serology impacts overall survival in children receiving first unrelated hematopoietic stem cell transplant for acute leukemia: European Society of Bone Marrow Transplantation Pediatric Diseases Working Party StudyElif Ince, Jaques-Emmanuel Galimard, Marianne Ifversen, et al.
Haematologica|November 3, 2025
<i>Erratum</i> to<i>: "</i>Donor cytomegalovirus serology impacts overall survival in children receiving first unrelated hematopoietic stem cell transplant for acute leukemia: European Society of Bone Marrow Transplantation Pediatric Diseases Working Party Study"Elif Ince, Jaques-Emmanuel Galimard, Marianne Ifversen, et al.
Pageof 10